Chengdu New Radiomedicine Technology Co. Ltd.

This early-phase trial is testing two new drugs for people with advanced solid tumors that have not responded to standard treatments. The first drug helps doctors see tumors on a PET scan, and the second delivers targeted radiation to destroy cancer cells. The study will check sa…